Cargando…
Fisetin as a Senotherapeutic Agent: Biopharmaceutical Properties and Crosstalk between Cell Senescence and Neuroprotection
Like other organs, brain functions diminish with age. Furthermore, for a variety of neurological disorders—including Alzheimer’s disease—age is one of the higher-risk factors. Since in many Western countries the average age is increasing, determining approaches for decreasing the effects of aging on...
Autores principales: | Elsallabi, Osama, Patruno, Antonia, Pesce, Mirko, Cataldi, Amelia, Carradori, Simone, Gallorini, Marialucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839434/ https://www.ncbi.nlm.nih.gov/pubmed/35164003 http://dx.doi.org/10.3390/molecules27030738 |
Ejemplares similares
-
Characterization and Valorization of ‘Sulmona Red Garlic’ Peels and Small Bulbs
por: Lasalvia, Alba, et al.
Publicado: (2022) -
Fisetin is a senotherapeutic that extends health and lifespan
por: Yousefzadeh, Matthew J., et al.
Publicado: (2018) -
Quantum Molecular Resonance Inhibits NLRP3 Inflammasome/Nitrosative Stress and Promotes M1 to M2 Macrophage Polarization: Potential Therapeutic Effect in Osteoarthritis Model In Vitro
por: Paolucci, Teresa, et al.
Publicado: (2023) -
The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets
por: Rossi, Martina, et al.
Publicado: (2021) -
The Up-Regulation of Oxidative Stress as a Potential Mechanism of Novel MAO-B Inhibitors for Glioblastoma Treatment
por: Marconi, Guya Diletta, et al.
Publicado: (2019)